Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Crystal Structure of Liguzinediol, 2,5-Dimethylol-3,6-dimethylpyrazine

Journal Article · · Crystallography Reports
; ; ; ; ; ; ;  [1]
  1. Nanjing University of Chinese Medicine, School of Pharmacy (China)
The 2,5-dimethylol-3,6-dimethylpyrazine, C{sub 8}H{sub 12}N{sub 2}O{sub 2}, liguzinediol, has been recently discovered as a potential agent for the treatment of heart failure with low safety risk. The crystal structure of liguzinediol, which has been determined by single-crystal X-ray diffraction analysis, is reported for the first time. The liguzinediol crystal may be obtained from 50% ethanol or ethyl acetate. The compound crystallizes in the monoclinic system with the sp. gr. P2{sub 1}/n and the unit cell parameters a = 4.0560(8) Å, b = 12.280(3) Å, c = 8.5370(17) Å, β = 96.93(3)°, Z = 2. The molecule forms S{sub 2}-symmetric conformation in the crystal. The hydroxyl H atom forms short intermolecular contacts with the neighbouring pyrazine N atom, which forms the weak hydrogen bonds in the crystal.
OSTI ID:
22758202
Journal Information:
Crystallography Reports, Journal Name: Crystallography Reports Journal Issue: 5 Vol. 63; ISSN 1063-7745; ISSN CYSTE3
Country of Publication:
United States
Language:
English